A recent study looked at the performance of two open-source AI pathology models for predicting EGFR mutations status across independent cohorts and ancestral subgroups in patients with lung cancer.
Researchers found that AI model performance declined in certain ancestry groups—despite higher EGFR mutation prevalence. Which explanation best accounts for this observation?
